UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lipocalin‐2 negatively modulates the epithelial‐to‐mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF‐beta1)/Lcn2/Twist1 pathway

Hepatology (Baltimore, Md.), 2013-10, Vol.58 (4), p.1349-1361

2013

Volltextzugriff (PDF)

Activation of mammalian target of rapamycin complex 1 (mTORC1) and Raf/Pyk2 by growth factor‐mediated Eph receptor 2 (EphA2) is required for cholangiocarcinoma growth and metastasis

Hepatology (Baltimore, Md.), 2013-06, Vol.57 (6), p.2248-2260

2013

Volltextzugriff (PDF)

EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma

International journal of cancer, 2010-02, Vol.126 (4), p.940-949

2010

Volltextzugriff (PDF)

Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer

Experimental and Molecular Medicine, 2018, 50(0), , pp.1-10

2018

Volltextzugriff (PDF)

Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma

BMC cancer, 2011-02, Vol.11 (1), p.78-78, Article 78

2011

Volltextzugriff (PDF)

OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways

Oncotarget, 2017-03, Vol.8 (11), p.18129-18144

2017

Volltextzugriff (PDF)

Isolation of EpCAM+/CD133− hepatic progenitor cells

Molecules and Cells, 2013, 36(5), , pp.424-431

2013

Volltextzugriff (PDF)

Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma

Experimental and Molecular Medicine, 2012, 44(3), , pp.214-224

2012

Volltextzugriff (PDF)

Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells

Experimental and Molecular Medicine, 2009, 41(2), , pp.102-115

2009

Volltextzugriff (PDF)

Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression

Journal of hepatology, 2015-06, Vol.62 (6), p.1278-1286

2015

Volltextzugriff (PDF)

Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells

Experimental and Molecular Medicine, 2010, 42(11), , pp.787-797

2010

Volltextzugriff (PDF)

C-terminal-truncated HBV X promotes hepato-oncogenesis through inhibition of tumor-suppressive β-catenin/BAMBI signaling

Experimental & molecular medicine, 2016-12, Vol.48 (12), p.e275-e275

2016

Volltextzugriff (PDF)

C-terminal-truncated HBV X promotes hepato-oncogenesis through inhibition of tumor-suppressive β-catenin/BAMBI signaling

Experimental and Molecular Medicine, 2016, 48(0), , pp.1-10

2016

Volltextzugriff (PDF)

C-terminal-truncated HBV X promotes hepato-oncogenesis through inhibition of tumor-suppressive [beta]-catenin/BAMBI signaling

Experimental & molecular medicine, 2016-12, Vol.48 (12)

2016

Volltextzugriff (PDF)

Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells

Experimental & molecular medicine, 2010, Vol.42 (11), p.787-797

2010

Volltextzugriff (PDF)

Isolation of EpCAM^sup +^/CD133^sup -^ hepatic progenitor cells

Molecules and cells, 2013-11, Vol.36 (5), p.424

2013

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)

Sprache

Englisch
(15)
Koreanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Lipocalin‐2 negatively modulates the epithelial‐to‐mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF‐beta1)/Lcn2/Twist1 pathway

Activation of mammalian target of rapamycin complex 1 (mTORC1) and Raf/Pyk2 by growth factor‐mediated Eph receptor 2 (EphA2) is required for cholangiocarcinoma growth and metastasis

EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma

Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer

Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma

OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways

Isolation of EpCAM+/CD133− hepatic progenitor cells

Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma

Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells

Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression

Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells

C-terminal-truncated HBV X promotes hepato-oncogenesis through inhibition of tumor-suppressive β-catenin/BAMBI signaling

C-terminal-truncated HBV X promotes hepato-oncogenesis through inhibition of tumor-suppressive β-catenin/BAMBI signaling

C-terminal-truncated HBV X promotes hepato-oncogenesis through inhibition of tumor-suppressive [beta]-catenin/BAMBI signaling

Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells

Isolation of EpCAM^sup +^/CD133^sup -^ hepatic progenitor cells

Suchergebnisse filtern